SPONSOR
Gan & Lee Pharmaceuticals.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1
Gan & Lee Pharmaceuticals. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Obesity/Overweight in Adult, Obesity/Overweight.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gan & Lee Pharmaceuticals.
How many clinical trials has Gan & Lee Pharmaceuticals. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Gan & Lee Pharmaceuticals., of which 2 are actively recruiting participants. These trials cover conditions including Obesity/Overweight in Adult, Obesity/Overweight. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gan & Lee Pharmaceuticals. research focus on?
Gan & Lee Pharmaceuticals. clinical trials span Obesity/Overweight in Adult, Obesity/Overweight. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gan & Lee Pharmaceuticals. clinical trial?
To participate in a Gan & Lee Pharmaceuticals. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gan & Lee Pharmaceuticals. trials with current recruitment status updated daily.
Clinical Trials by Gan & Lee Pharmaceuticals.
NCT07150975 Phase 3
Recruiting
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Obesity/Overweight in Adult
NCT07141030 Phase 1
Recruiting
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
Obesity/Overweight
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology